HIV-1-infection
Showing NaN - NaN of 9
HIV-1-infection Trial (Cabotegravir/Rilpivirine, Antiretroviral)
Recruiting
- HIV-1-infection
-
Kisumu, Kenya
- +6 more
Feb 1, 2023
HIV-1-infection Trial in Worldwide (Once daily CAB tablet + RPV tablet, Long acting CAB injectable + long acting RPV injectable)
Not yet recruiting
- HIV-1-infection
- Once daily CAB tablet + RPV tablet
- Long acting CAB injectable + long acting RPV injectable
-
Atlanta, Georgia
- +11 more
Dec 13, 2022
HIV-1-infection, Pregnancy Related Trial in Cape Town, Kampala (Dolutegravir, Standard of Care (EFV + 2 NRTI backbone))
Active, not recruiting
- HIV-1-infection
- Pregnancy Related
- Dolutegravir
- Standard of Care (EFV + 2 NRTI backbone)
-
Cape Town, Western Cape, South Africa
- +1 more
Aug 8, 2022
HIV-1-infection Trial in Kampala (Integrating PrEP delivery)
Enrolling by invitation
- HIV-1-infection
- Integrating PrEP delivery
-
Kampala, UgandaInfectious Diseases Institute, Makerere University
Mar 28, 2022
Emergence of HIV Drug Resistance Following Initiation of TLD
Recruiting
- HIV-1-infection
-
Port-au-Prince, Bicentaire, Haiti
- +13 more
Feb 22, 2022
HIV-1-infection, Malnutrition, Child Trial in Kampala (Ceftriaxone Sodium, Ampicillin, Gentamicin)
Recruiting
- HIV-1-infection
- Malnutrition, Child
- Ceftriaxone Sodium
- +2 more
-
Kampala, Central, UgandaMakerere University College of Health Sciences
Sep 24, 2021
HIV-1-infection Trial in Worldwide (3BNC117-LS-J, 10-1074-LS-J, Combination 3BNC117-LS-J and 10-1074-LS-J)
Unknown status
- HIV-1-infection
- 3BNC117-LS-J
- +6 more
-
Boston, Massachusetts
- +8 more
Dec 11, 2020
HIV-1-infection, Contraception Trial in Kampala (Levonorgestrel two rod sub-dermal implant, Rilpivirine, Darunavir+Ritonavir)
Unknown status
- HIV-1-infection
- Contraception
- Levonorgestrel two rod sub-dermal implant
- +2 more
-
Kampala, UgandaInfectious Diseases Institue
Mar 26, 2019